Investigation of the Sox-9 and Cited-1 Immune Activity in Placentas of Women with Placenta Accreta

Year 2023, Volume: 5 Issue: 2, 332 - 6, 15.05.2023

Senem Akalın , Ece Öcal , Engin Deveci

https://doi.org/10.37990/medr.1239182

Abstract

Aim: In this study, we investigated the immune activity of the Sox-9 and Cited-1 in women with placenta accreta.
Material and Methods: 20 healthy and 20 placenta accreta were processed for routine histological tissue processing. Placentals samples were dissected and fixed in 10% formaldehyde solution. Samples were embedded in paraffin blocks. Clinical and biochemical parameters were recorded. Placental sections were cut from paraffin blocks and stained with Sox-9 and Cited-1 immunostaining.
Results: In our study, control group showed negative Cited-1 expression in decidual cells, root villi and connective tissue areas in general. Placenta accreta group showed increased Cited-1 expression in degenerated decidual cells, fibroblastic cells and endothelium. In control group, Sox-9 expression was negative in the syncytial knots, in the vascular endothelial cells. In placenta accreta group, Sox-9 reaction was positive in the root villi, in the blood vessels, in the connective tissue.
Conclusion: It was observed that the Sox-9 reaction was increased and inflammation was induced, depending on the differences in decidual cells, in the syncytial area and in the vascular endothelium in in placentas of women with placenta accreta. It is thought that Sox-9 signaling processes are being determined and Cited-1 may be stimulants that affect cell proliferation and angiogenesis regulation and affect placental development.

Keywords

Placenta accreta, Sox-9, Cited-1, immunostaining

References

• Jansen CHJR, Kastelein AW, Kleinrouweler CE, et al. Development of placental abnormalities in location and anatomy. Acta Obstet Gynecol Scand. 2020;99:983-93.
• Oğlak SC, Ölmez F, Tunç Ş. Evaluation of Antepartum Factors for Predicting the Risk of Emergency Cesarean Delivery in Pregnancies complicated with placenta previa. Ochsner J. 2022;22:146-53.
• Papanikolaou IG, Domali E, Daskalakis G, et al. Abnormal placentation: Current evidence and review of the literature. Eur J Obstet Gynecol Reprod Biol. 2018;228:98-105.
• Burton GJ, Jauniaux E. What is the placenta? Am J Obstet Gynecol. 2015; 13:6.e1,6-8.
• Bartels HC, Postle JD, Downey P, Brennan DJ. Placenta accreta spectrum: a review of pathology, molecular biology, and biomarkers. Dis Markers. 2018;2018:1507674.
• Bailit JL, Grobman WA, Rice MM, et al. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol. 2015;125:683-9.
• Ozkose ZG, Oglak SC, Behram M, et al. Maternal Serum Cripto-1 Levels in Pregnancies Complicated with Placenta Previa and Placenta Accreta Spectrum (PAS). J Coll Physicians Surg Pak. 2022;32:1570-75.
• Aşır F, Nergiz Y, Pala A. Vitamin E protected the mouse adrenal gland against immobilization stress. Pol J Vet Sci. 2022;25:447-54.
• Durgun C, Aşır F. Effect of ellagic acid on damage caused by hepatic ischemia reperfusion in rats. Eur Rev Med Pharmacol Sci. 2022;26:8209-15.
• Ölmez F, Oğlak SC, Gedik Özköse Z. Increased maternal serum aquaporin-9 expression in pregnancies complicated with early-onset preeclampsia. J Obstet Gynaecol Res. 2022;48:647-53.
• Özköse ZG, Oğlak SC, Ölmez F. The comparison of maternal and neonatal outcomes between planned and emergency cesarean deliveries in placenta previa patients without placenta accreta spectrum. Ginekol Polska. 2022;93:217-23.
• Gibbins KJ, Einerson BD, Varner MW, Silver RM. Placenta previa and maternal hemorrhagic morbidity. J Matern Fetal Neonatal Med. 2018;31:494-9.
• Oğlak SC, Obut M. Does keeping the Bakri balloon in place for longer than 12 hours provide favourable clinical outcomes in the treatment of uterine atony? Ege Tıp Dergisi. 2020;59:209-14.
• Oğlak SC, Tunç Ş, Obut M, et al. Maternal near-miss patients and maternal mortality cases in a Turkish tertiary referral hospital. Ginekol Pol. 2021;92:300-5.
• Oglak SC, Obut M, Tahaoglu AE, et al. A prospective cohort study of shock index as a reliable marker to predict the patient's need for blood transfusion due to postpartum hemorrhage. Pak J Med Sci. 2021;37:863-8.
• Otçu S, Deveci E. Immunohistochemical analysis of hypoxia-inducible factor 1-Alpha and Ki-67 expression in placenta previa and accreta. Anal Quant Cytol Histol. 2021;43:143-9.
• Biswas R, Sawhney H, Dass R, et al. Histopathological study of placental bed biopsy in placenta previa. Acta Obstet Gynecol Scand. 1999;78:173-9.
• Silver RM. Abnormal placentation: placenta previa, vasa previa, and placenta accreta. Obstet Gynecol. 2015;126:654-68.
• Jung EJ, Cho HJ, Byun JM, et al. Placental pathologic changes and perinatal outcomes in placenta previa. Placenta. 2018;63:15-20.
• Gerstner JR, Landry CF. Expression of the transcriptional coactivator CITED1 in the adultand developing murine brain. Dev Neurosci. 2007;29:203-12.
• Yahata T, Shao W, Endoh H, et al. Selective coactivation of estrogen-dependent transcription by CITED1CBP/p300-binding protein. Genes Dev. 2001;15:2598-2612.
• Sriraman V, Sinha M, Richards JS. Progesterone receptor-induced gene expression in primary mouse granulosa cell cultures. Biol Reprod. 2010;82:402-12.
• Hatzirodos N, Hummitzsch K, Irving-Rodgers HF, et al. Transcriptome profiling of granulosa cells from bovine ovarian follicles during atresia. BMC Genomics. 2014;15:40.
• Jo A, Denduluri S, Zhang B, et al. The versatile functions of Sox-9 in development, stem cells, and human diseases. Genes Dis. 2014;1:149-61.
• Aguilar-Medina M, Avendaño-Félix M, Lizárraga-Verdugo E, et al. Sox-9 stem-cell factor: clinical and functional relevance in cancer. J Oncol. 2019;2019:6754040.
• Sekido R, Bar I, Narváez V, et al. Sox-9 is up-regulated by the transient expression of SRY specifically in Sertoli cell precursors. Dev Biol. 2004;274:271-9.
• Zhao J, Patel J, Kaur S, et al. Sox-9 and Rbpj differentially regulate endothelial to mesenchymal transition and wound scarring in murine endovascular progenitors. Nat Commun. 2021;12:2564.
• Xian L, Georgess D, Huso T, et al. HMGA1 amplifies Wnt signalling and expands the intestinal stem cell compartment and Paneth cell niche. Nat Commun. 2017;8:15008.